Add-On tolterodine extended release improves overactive bladder symptoms in men receiving alpha-blocker therapy

被引：0
作者：
Chapple, C. [1 ]
Abrams, P. [2 ]
Herschorn, S. [3 ]
Sun, F. [4 ]
Brodsky, M. [5 ]
Guan, Z. [5 ]
机构：
[1] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England
[2] Bristol Urol Inst, Dept Urol, Bristol, Avon, England
[3] Univ Toronto, Dept Urol, Toronto, ON, Canada
[4] Pfizer Inc, Dept Stat, New York, NY USA
[5] Pfizer Inc, Dept Med Urol, New York, NY USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
[41]   INDIVIDUALIZED ADD-ON TREATMENT BASED ON THE DIFFERENCE OF RECEPTOR OF ALPHA BLOCKER IN ANIMAL MODELS OF OVERACTIVE BLADDER AND BENIGN PROSTATE HYPERPLASIA [J].
Cho, Sung Tae ;
Choi, Don Kyoung ;
Kwon, Ohseong ;
Kim, Khae Hawn ;
Han, Ji-Yeon .
NEUROUROLOGY AND URODYNAMICS, 2018, 37 :S540-S541
[42]   Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo -controlled Study (MATCH) [J].
Kakizaki, Hidehiro ;
Lee, Kyu-Sung ;
Yamamoto, Osamu ;
Jong, Jar Jar ;
Katou, Daisuke ;
Sumarsono, Budiwan ;
Uno, Satoshi ;
Yamaguchi, Osamu .
EUROPEAN UROLOGY FOCUS, 2020, 6 (04) :729-737
[43]   Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score [J].
Kaplan, Steven A. ;
Roehrborn, Claus G. ;
Chancellor, Michael ;
Carlsson, Martin ;
Bavendam, Tamara ;
Guan, Zhonghong .
BJU INTERNATIONAL, 2008, 102 (09) :1133-1139
[44]   Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS) [J].
Kaplan, Steven A. ;
Herschorn, Sender ;
McVary, Kevin T. ;
Staskin, David ;
Chapple, Christopher ;
Foley, Steve ;
Santos, Javier Cambronero ;
Kristy, Rita M. ;
Choudhury, Nurul ;
Hairston, John ;
Schermer, Carol R. .
JOURNAL OF UROLOGY, 2020, 203 (06) :1163-1171
[45]   BLADDER DYSFUNCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS REFRACTORY TO ALPHA-BLOCKER THERAPY - A VIDEOURODYNAMIC ANALYSIS AND THE RELATIONSHIP WITH AGE AND PROSTATIC VOLUME [J].
Wu, S. ;
Kuo, H. .
NEUROUROLOGY AND URODYNAMICS, 2015, 34 :S73-S74
[46]   EFFICACY AND SAFETY OF ADD-ON MIRABEGRON VS. PLACEBO TO TAMSULOSIN IN MEN WITH OVERACTIVE BLADDER SYMPTOMS (MATCH STUDY) [J].
Kakizaki, Hidehiro ;
Lee, Kyu-Sung ;
Yamamoto, Osamu ;
Jong, Jar Jar ;
Katou, Daisuke ;
Sumarsono, Budiwan ;
Uno, Satoshi ;
Yamaguchi, Osamu .
JOURNAL OF UROLOGY, 2018, 199 (04) :E988-E988
[47]   Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder [J].
Kelleher, CJ ;
Kreder, KJ ;
Pleil, AM ;
Burgess, SM ;
Reese, PR .
AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (19) :S616-S630
[48]   Desmopressin Add-On Therapy for Refractory Nocturia in Men Receiving α-Blockers for Lower Urinary Tract Symptoms [J].
Bae, Woong Jin ;
Bae, Jang Ho ;
Kim, Sae Woong ;
Chung, Byung Ha ;
Kim, Jang Hwan ;
Kim, Choung Soo ;
Lee, Hyun Moo ;
Lee, Kyung Seop ;
Yoo, Tag Keun ;
Kim, Sun Il ;
Byun, Seok Soo ;
Lee, Ji Youl .
JOURNAL OF UROLOGY, 2013, 190 (01) :180-186
[49]   Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study [J].
Herschorn, Sender ;
McVary, Kevin T. ;
Santos, Javier Cambronero ;
Foley, Steve ;
Kristy, Rita M. ;
Choudhury, Nurul ;
Hairston, John ;
Kaplan, Steven A. .
UROLOGY, 2021, 147 :235-242
[50]   Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study [J].
Hidehiro Kakizaki ;
Kyu-Sung Lee ;
Daisuke Katou ;
Osamu Yamamoto ;
Budiwan Sumarsono ;
Satoshi Uno ;
Osamu Yamaguchi .
Advances in Therapy, 2021, 38 :739-757
12345